Arcus Biosciences Inc. (RCUS)
Market Closed
17 Jul, 20:00
NYSE NYSE Primary $
27. 37
+0.73
+2.7402%
$
2.82B Market Cap
- P/E Ratio
- Div Yield
781,600 Volume
-3.48 Eps
$ 26.64
Previous Close 
Want to track RCUS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Arcus Biosciences Inc. (RCUS) Statistics
Valuation metrics
Market Cap 2.82B
Enterprise value 2.67B
Trailing P/E (ttm) -8.64
Forward P/E -
PEG ratio -0.38
Price/Sales (ttm) 11.68
Price/Book (mrq) 6.55
Enterprise Value/Revenue 11.3
Enterprise Value/EBITDA -8.08
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 684.41K
Average volume (90 days) 1.36M
Price summary
52-Week low 8.84
52-Week high 31.73
Beta -
50-Day moving average 27.07
200-Day moving average 22.87
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1.56%
Operating margin -1.69%
Operational effectiveness
Return on assets -0.37%
Return on equity -0.69%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1.88
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.94
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 6.56
Total debt (mrq) -
Total Debt/Equity (mrq) 0.22
Current ratio (mrq) 4.04%
Book value per share (mrq) 4.18
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
